New research finds possible treatment for latent HIV. Valproic acid used to deplete HIV

Abstract

Researchers have discovered a possible combination therapy that will help clear HIV from resting CD4 T-cells, which may open the doors to a new approach to eliminating HIV infection. The recent study shows that highly-active antiretroviral therapy (HAART) with subcutaneous enfuvirtide, the fusion inhibitor, plus oral valproic acid accelerated the clearance of HIV from resting T-cells in vivo.